Provided by Tiger Fintech (Singapore) Pte. Ltd.

ALX Oncology Holdings

0.5041
-0.0262-4.94%
Volume:251.40K
Turnover:127.23K
Market Cap:26.91M
PE:-0.20
High:0.5399
Open:0.5275
Low:0.4902
Close:0.5303
Loading ...
Jul 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 17, 2024

Major Issues Report

Form 8-K - Current report
Jun 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
May 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 02, 2024

Major Issues Report

Form 8-K - Current report
Apr 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 08, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 08, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 07, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 26, 2023

Major Issues Report

Form 8-K - Current report
Dec 20, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2023

Major Issues Report

Form 8-K - Current report